© 2015

Hodgkin Lymphoma

A Comprehensive Overview

  • Andreas Engert
  • Anas Younes


  • Evaluates new treatment options for both first-line and relapsed disease

  • Offers clear guidance on management of special patient groups and Hodgkin survivors

  • Discusses pathogenesis, clinical evaluation, imaging diagnosis, staging systems, and prognostic factors


Part of the Hematologic Malignancies book series (HEMATOLOGIC)

Table of contents

  1. Front Matter
    Pages i-xv
  2. Epidemiology and Pathogenesis

    1. Front Matter
      Pages 1-1
    2. Sally L. Glaser, Ellen T. Chang, Christina A. Clarke, Theresa H. Keegan
      Pages 3-26
    3. Andreas Rosenwald, Ralf Küppers
      Pages 45-64
    4. Lydia Visser, Anke van den Berg, Sibrand Poppema, Arjan Diepstra
      Pages 65-78
    5. Christian Steidl, Randy D. Gascoyne
      Pages 79-92
  3. Diagnosis and First-Line Treatment

    1. Front Matter
      Pages 93-93
    2. Jim Armitage, Christian Gisselbrecht
      Pages 95-106
    3. Andrea Gallamini, Martin Hutchings, Anna Borra
      Pages 107-130
    4. Lena Specht, Dirk Hasenclever
      Pages 131-155
    5. Joachim Yahalom, Richard T. Hoppe
      Pages 157-176
    6. Peter Johnson, David Straus
      Pages 177-199
    7. Pieternella Lugtenburg, Anton Hagenbeek
      Pages 201-220
    8. John M. M. Raemaekers, Andreas Engert
      Pages 221-234
    9. Peter Borchmann, Massimo Federico, Volker Diehl
      Pages 235-250
  4. Special Clinical Situations

    1. Front Matter
      Pages 251-251
    2. Georgina W. Hall, Cindy L. Schwartz, Stephen Daw, Louis S. Constine
      Pages 253-270
    3. Boris Böll, Andrew M. Evens
      Pages 271-286
    4. Dennis A. Eichenauer, Michelle A. Fanale
      Pages 287-295

About this book


This book examines in detail the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the management appropriate in special clinical circumstances, including in the elderly, pregnant women, and those with lymphocyte-predominant disease. Careful attention is devoted to the emerging individually tailored treatment strategies that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The second edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by the key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.



CD30 Combined modality treatment Late effects Microenvironment PET

Editors and affiliations

  • Andreas Engert
    • 1
  • Anas Younes
    • 2
  1. 1.Universitätsklinikum Köln Klinik I für Innere MedizinKölnGermany
  2. 2.Memorial Sloan - Kettering Cancer CenterNew YorkUSA

Bibliographic information

  • Book Title Hodgkin Lymphoma
  • Book Subtitle A Comprehensive Overview
  • Editors Andreas Engert
    Anas Younes
  • Series Title Hematologic Malignancies
  • Series Abbreviated Title Hematologic Malignancies
  • DOI
  • Copyright Information Springer International Publishing 2015
  • Publisher Name Springer, Cham
  • eBook Packages Medicine Medicine (R0)
  • Hardcover ISBN 978-3-319-12504-6
  • Softcover ISBN 978-3-319-37451-2
  • eBook ISBN 978-3-319-12505-3
  • Series ISSN 2197-9766
  • Series E-ISSN 2197-9774
  • Edition Number 2
  • Number of Pages XV, 437
  • Number of Illustrations 32 b/w illustrations, 50 illustrations in colour
  • Topics Hematology
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Oncology & Hematology


“The book, divided into five sections, consists of 437 pages, enriched by figures, tables, schema and an updated bibliography. … Intended primarily as an updated publication for oncologists and haematologists, this volume may stimulate the interest of specialists involved in oncology, as well as members of the broader medical community who have a strong interest in Hodgkin’s lymphoma. Nuclear physicians and radiologists may also find the material to be of particular relevance … .” (Flavia Galante and Luigi Mansi, European Journal of Nuclear Medicine and Molecular Imaging, Vol. 43, 2016)